COOH. In this report, a series of C-terminal truncations and fusion with a human c-myc epitope tag allowed identification of a tenth HCV-encoded cleavage product, p7, which is located between the E2 and NS2 proteins. As determined by N-terminal sequence analysis, p7 begins with position 747 of the HCV H strain polyprotein. p7 is preceded by a hydrophobic sequence at the C terminus of E2 which may direct its translocation into the endoplasmic reticulum, allowing cleavage at the E2/p7 site by host signal peptidase. This hypothesis is supported by the observation that cleavage at the E2/p7 and p7/NS2 sites in cell-free translation studies was dependent upon the addition of microsomal membranes. However, unlike typical cotranslational signal peptidase cleavages, pulse-chase experiments indicate that cleavage at the E2/p7 site is incomplete, leading to the production of two E2-specific species, E2 and E2-p7. Possible roles of p7 and E2-p7 in the HCV life cycle are discussed.
Hepatitis C viruses (HCV) have recently been recognized as agents of the parentally transmitted form of non-A, non-B hepatitis (10, 40) . HCV causes the vast majority of transfusionassociated cases of hepatitis and a significant proportion of community-acquired hepatitis worldwide (reviewed in references 34 and 36) . HCV infection results in various clinical outcomes, including acute hepatitis, chronic hepatitis, cirrhosis, and establishment of an asymptomatic carrier state which may persist for life (reviewed in reference 34). Chronic infections are frequent, perhaps universal, and have been associated with increased incidence of hepatocellular carcinoma (13, 62) .
The genome structures of several HCV isolates have been elucidated (9, 11, 14, 30, 38, 39, 52, 54, 55, 66, 67) , indicating the existence of several genotypes (6, 65) . This group of closely related enveloped positive-strand viruses is now classified as a separate genus in the flavivirus family (22) , which includes two other genera, the flaviviruses (7) and pestiviruses (12) . The HCV genome RNA is approximately 9.4 kb in length and contains a highly conserved 5' noncoding region (29) followed by a long open reading frame encoding a polyprotein of 3,010 to 3,033 amino acids.
As established by cell-free translation and cell culture expression studies (2, 16, 25-27, 31-33, 47, 64, 68) , the HCV polyprotein is processed by cellular and viral proteinases to produce the putative viral structural and nonstructural (NS) proteins. The order and nomenclature of the cleavage products are as follows: NH2-C-E1-E2-NS2-NS3-NS4A-NS4B-NS5A-NSSB-COOH. C, a basic protein, is believed to be the viral capsid protein; El and E2 are probable virion envelope glycoproteins; NS2 through NS5B are putative NS proteins, at least some of which may be the functional equivalents of homologous proteins encoded by flaviviruses and pestiviruses (reviewed in references 36 and 50). Previous studies indicate that the host signal peptidase of the endoplasmic reticulum (ER) catalyzes cleavages in the putative structural region (C/El, E1/E2, and perhaps E2/NS2) (31) , whereas an HCVencoded serine proteinase located in the N-terminal one-third of the NS3 protein is responsible for four cleavages in the NS region (3/4A, 4A/4B, 4B/5A, and 5A/5B) (2, 16, 25, 32, 47, 68) .
Cleavage at the 2/3 site is mediated by a second HCV-encoded proteinase which encompasses the NS2 region and the NS3 serine proteinase domain (26, 32) .
Although the locations of most HCV-encoded proteins and the corresponding cleavage sites have been determined, the region between structural and NS coding sequences is still poorly defined. In a previous report, we observed at least two distinct forms of N-deglycosylated E2-specific proteins and suggested that an additional cleavage product might be present between the E2 and NS2 proteins (27) . In this study, we have identified this protein, called p7, by expression of a series of C-terminally truncated polyproteins and by fusion to a human c-myc epitope tag, which allowed isolation of the cleavage product and N-terminal sequence determination. p7 mapped between E2 and NS2. The presence of hydrophobic potential signal/anchor sequences preceding the E2/p7 and p7/NS2 cleavage sites and the results of cell-free translation analyses indicate that host signal peptidase may catalyze both of these cleavages. However, cleavage at the E2/p7 site is incomplete, leading to the production of two stable E2-specific proteins with different C termini, E2 and E2-p7.
MATERIALS AND METHODS
Plasmid constructions. Standard recombinant DNA techniques (63) were used for construction of the expression plasmids described below. Constructs for expression of polyproteins with serial C-terminal truncations in the E2-NS2 region were produced from pTM3/HCV1-966, which encodes For all of the constructs, three additional N-terminal residues (Met-Cys-Thr) are predicted to be present prior to the Met residue initiating the HCV-H polyprotein (27) .
b Restriction sites in the HCV cDNA used for the plasmid constructs. Nucleotide numbers given in parentheses refer to the positions of these sites in the full-length HCV-H sequence (14) , assuming that the 5' noncoding regions of HCV-H and HCV-1 (11, 29) are the same length. Restriction sites in boldface indicate that protruding ends were treated with T4 DNA polymerase prior to ligation to produce blunt ends.
c Restriction sites in plasthid vectors used for cloning.
d Number of predicted non-HCV C-terminal residues prior to the first termination codon.
HCV H strain (HCV-H) amino acid residues 1 to 966, by the subcloning strategies summarized in Table 1 .
Construction of pSINrepS/HCV171-379-myc and pSINrep5/ HCV370-802-myc will be described in detail elsewhere (44) . Briefly, a derivative of the Sindbis virus replicon expression construct pSINrepS (3), called pSINrepS/c-myc, was assembled; it contained, in the polycloning site region, a sequence encoding an XbaI recognition site followed by an MluI site, the coding sequence of the c-myc epitope recognized by monoclonal antibody (MAb) Mycl-9E10 (EQKLISEEDL) (18, 19) , and a UAA termination codon. Selected regions of the HCV coding region (as indicated by the HCV polyprotein residue numbers) were amplified by PCR to contain a 5' XbaI site, an AUG start codon, and a 3' Mlul site, allowing in-frame fusion with the c-myc epitope tag. PCR products were digested with XbaI and MluI and cloned into pSINrep5/c-myc.
pTM3/HCV364-802-myc was constructed by subcloning the SacI-XhoI fragment (847 bp) of pSINrep5/HCV370-802-myc and the NcoI-SacI fragment (893 bp) of pTM3/HCV1-1488 (27) into pTM3 (51), which had been digested with NcoI (27) . The corresponding vaccinia virus-HCV recombinant, vHCV1-3011, was generated by marker rescue on CV-1 cells (46) and identified by the gpt selection method (20) . Recom- binant viruses were plaque purified three times under selective conditions prior to growth of large-scale stocks. Stocks of vHCV1-3011, vHCV1-1488 (27) , and vTF7-3, a vaccinia virus recombinant expressing the T7 DNA-dependent RNA polymerase (24) , were grown in BSC-40 monolayers and partially purified (37) , and titers of infectious progeny were determined by plaque assay on BSC-40 cells (37) .
SINrep5/HCV-myc recombinant viruses were generated by using 5'-capped SP6 RNA transcripts from pSINrep5/HCVmyc and pDH(26S)5'SIN helper templates essentially as described previously (3) . The titers of these recombinants were determined by an infection assay using secondary cultures of chicken embryo fibroblasts (3, 23) . Briefly, cells were seeded in 35-mm-diameter tissue culture wells to produce subconfluent monolayers and were infected with serial dilutions of the SINrepS/HCV-myc recombinants (56 (59) .
Immunoprecipitates were solubilized and analyzed by SDSpolyacrylamide gel electrophoresis (PAGE) (41) . After treatment for fluorography with Enhance (Dupont), gels were dried and exposed at -70°C with prefogged (43) X-ray film (Kodak). 14C-methylated molecular mass marker proteins were purchased from Amersham.
In a previous report, endoglycosidase F (endo F) was utilized for characterization of the deglycosylated forms of HCV glycoproteins (27) . However, this material was unsuitable for N-terminal sequence analysis, possibly because of proteolysis or N-terminal modification during overnight endo F digestions. In this study, we used peptide N-glycosidase F (PNGaseF), which cleaves between the innermost acetylglycoamine and asparaginyl residues of high-mannose, hybrid, and complex oligosaccharides from N-linked glycoproteins. PNGaseF digestions were carried out essentially according to the manufacturer's instructions (New England Biolabs). Briefly, immunoprecipitates were resuspended in 50 mM sodium phosphate (pH 7.5) containing 0.5% SDS and 1% 2-mercaptoethanol and were heated for 10 min at 99°C. The clarified supernatants were adjusted to 50 mM sodium phosphate (pH 7.5) containing 1% Nonidet P-40, 10 mM EDTA, and 100 ,ug of phenylmethylsulfonyl fluoride per ml and were incubated for 60 min at 37°C in the presence or absence of PNGaseF. Usually, 1,000 U (New England Biolabs) of PNGaseF was sufficient for complete digestion of samples from 1.5 x 105 cells. In the presence of 1% Nonidet P-40, up to 0.3% SDS had no significant inhibitory effect on PNGaseF digestion. Digested samples were mixed with an equal volume of 2x Laemmli sample buffer (41) and analyzed by SDS-PAGE as described above.
N-terminal sequence analysis. HepG2-A16 cells were coinfected with vHCV1-1488 and vTF7-3 as described above. At 3 h postinfection, monolayers were washed twice with prewarmed MEM lacking the amino acid used for radiolabeling and labeled for 4 h in the same medium containing 2% FBS and 200 ,uCi of the indicated 3H-labeled amino acid per ml. The 3H-amino acids used were leucine (135 Ci/mmol), valine (30 Ci/mmol), and threonine (17.7 Ci/mmol) (Amersham). After labeling, cell lysates were prepared and immunoprecipitated with either an El-specific mouse MAb (A4; kindly provided by H. Hsu and H. Greenberg, Stanford University) or an E2-specific rabbit polyclonal antiserum (WU 105) (27) as described above. Radiolabeled El-and E2-specific proteins were solubilized and digested with PNGaseF. The digested products were separated by SDS-PAGE, transferred to Immobilon polyvinylidene difluoride membranes (48) , and localized by autoradiography. Partial amino acid sequence analyses of El-and E2-specific proteins were performed as described previously (8) .
BHK-21 cells were infected with SINrepS/HCV-myc recombinants with a multiplicity of infection of 5 infectious units per cell. At 3 h postinfection, monolayers were washed twice with prewarmed MEM lacking leucine and labeled for 4 h at 37°C in MEM lacking leucine and containing 2% FBS and 200 ,uCi of [3H]leucine per ml. After labeling, monolayers were lysed with 0.5% SDS lysis buffer (as described above) and the proteins were immunoprecipitated with MAb Mycl-9E10 (19) , specific for a c-myc epitope tag (18 (27) (Fig. 1A) . These experiments identified the 21-kDa C protein and the El protein, gp3l, which was heavily modified by N-linked glycosylation and migrated to 21 kDa after endo F treatment (17) . Glycosylated E2-specific proteins gp88 and gp7O were resolved as three species of 62, 41, and 36 kDa after digestion with endo F (reference 27 and also below). p62 (the deglycosylated form of gp88) was identified as an E2-NS2 polyprotein and proposed as a potential precursor for the E2 and NS2 proteins. Neither p41 nor p36 was recognized by El or NS2 region-specific antiserum, suggesting the existence of at least two alternative forms of E2 (27) . To further examine the structural basis for these alternative forms of E2, we determined the N-terminal sequences of p41 and p36. Metabolically labeled lysates were prepared from HepG2-A16 cells which had been coinfected with vTF7-3 and vHCV1-1488, a vaccinia virus recombinant expressing the entire HCV structural region through the N-terminal twothirds of NS3. Samples were immunoprecipitated with E2-or El-specific antiserum, digested with PNGaseF, separated by SDS-PAGE, electroblotted onto Immobilon polyvinylidene difluoride membranes, and sequenced for 15 to 18 cycles of Edman degradation. For both p41 and p36, threonine residues were recovered at positions 2 and 5 (Fig. 2) . This finding, along with the sizes and immunoreactivities of these species, identifies Glu-384 as the N-terminal residue of both forms of HCV-H E2. Identical N-terminal sequences were obtained for unresolved glycosylated forms of E2, produced by cell-free translation in the presence of microsomal membranes (HCV-J strain) (31) or purified from cells infected with a vaccinia virus recombinant (HCV-1 strain) (57) . For the deglycosylated El protein, a leucine residue was recovered at position 9, valine residues were recovered at positions 3 and 12, and a threonine residue was recovered at position 13 (Fig. 2) . These results establish the N terminus of HCV-H El as Tyr-192, which is again consistent with the previously reported El sequence data for the HCV-J (31) and HCV-1 (57) strains. p41 and p36 differ at their C termini. We mapped the C-terminal boundaries of p41 and p36 by expressing a series of polyproteins with progressive C-terminal truncations (diagrammed in Fig. 1B (27) . The number at the top of each cleavage product indicates the position of its N-terminal residue in the polyprotein sequence. The apparent molecular mass of each HCV protein (p) and glycoprotein (gp) is indicated under the corresponding product (in kilodaltons). Regions containing predominantly uncharged amino acids are indicated as black bars. The region between E2 and NS2 which may represent an additional HCV-encoded protein is indicated (?). Also shown are putative cleavage sites for host signalase (*) (31), the HCV NS2-3 proteinase (I) (26, 32) , the NS3 serine proteinase (4X) ( E2-specific antiserum and digested with PNGaseF. As described previously, polyprotein 1-1488, which extends through the N-terminal two-thirds of the NS3 region, produced three E2-specific products: p62, p41, and p36 (Fig. 3) . Polyproteins terminating at residues 836, 786, and 762 produced only two E2-specific proteins after PNGaseF digestion, one of which comigrated with p36 (Fig. 3) . The second E2-specific product generated from polyprotein 1-836 migrated slightly more slowly than p41 and, therefore, may represent an uncleaved polyprotein containing p41 followed by the N-terminal 27 residues of NS2. The apparent molecular masses of truncated E2-specific proteins produced by polyproteins 1-786 and 1-762 were 39 and 38 kDa, respectively. These results suggest that the C terminus of p41 maps between residues 786 and 836, most likely at residue 809. Polyproteins terminating at residues 729, 700, and 660 generated only one E2-specific product of 35, 34, and 32 kDa, respectively (Fig. 3) , which indicates that the C terminus of p36 is located between residues 729 and 762, probably near residue 745 (see below). On the basis of these data, we refer to the small, highly hydrophobic region between E2 and NS2 as p7 (although its existence as a stable cleavage product has not been verified). p62, p41, and p36 are hereafter called E2-NS2, E2-p7, and E2, respectively.
Determination of the E2/p7 cleavage site. Further characterization of the putative p7 cleavage product has proven difficult. To generate p7-specific antiserum, we subcloned the cDNA sequence encoding HCV residues 745 to 809 into Escherichia coli expression constructs and attempted to purify p7-containing proteins in sufficient quantities to generate rabbit polyclonal antiserum. Although numerous E. coli expression systems have been tried, this approach has not yet succeeded. We also screened antisera from HCV-positive patients by immunoprecipitation under either denaturing or nondenaturing conditions; none of these sera reacted with a distinguishable p7 protein. It is possible that the putative p7 cleavage product is unstable or poorly immunogenic because of the highly hydrophobic nature of this region.
Because of the lack of antiserum specific for the p7 region, a 10-amino-acid c-myc epitope tag was fused to the p7 C terminus to allow identification of this processing product (diagrammed in Fig. 1B) . Construct HCV370-802-myc contains HCV residues 370 to 802, beginning in the putative signal peptide sequence at the C terminus of El, followed by the E2 and p7 regions. As a control for the specificity of the c-myc MAb, we constructed HCV171-379-myc, which includes the putative signal peptide at the C terminus of the C protein followed by the El region and the c-myc peptide. For Fig. 6B , microsomes were also required for processing of the longer polyprotein 364-1207 at the E2/p7 and p7/NS2 sites, as evidenced by the appearance of the E2 and E2-p7 glycoproteins and NS2. Both glycoproteins were fully protected against proteinase K digestion in the absence of detergent (data not shown). The E2/p7 cleavage was incomplete, in contrast to the efficient cleavage observed at the p7/NS2 site. The addition of microsomal membranes had no effect on the efficiency of cleavage at the 2/3 site in 364-1207, which is consistent with the membrane-independent autoproteolytic processing at this site by the HCV NS2-3 proteinase (26, 32) .
Kinetics of processing in the structural-NS2 region. To identify possible precursors involved in the structural-NS2 region processing, pulse-chase experiments were carried out in HepG2-A16 cells with a vaccinia virus-HCV recombinant, vHCV1-3011. As shown in Fig. 7A , the El protein was readily apparent after a 20-min pulse and was not associated with any higher-molecular-weight polyprotein precursors, which is consistent with the proposed cotranslational cleavage at both C/El and El/E2 sites by ER signal peptidase (31) . No From these data, the N-terminal sequence of p7 begins at HCV-H polyprotein residue 747 and is shown at the top of the graph. Leucine residues determined by N-terminal sequencing are in boldface type; the remaining residues are deduced from HCV-H nucleotide sequence data (14, 38) .
deglycosylated El migration was observed during the chase period (Fig. 7A) , suggesting that El does not undergo further proteolytic processing under these conditions. However, Nglycosylated forms of El did show a gradual increase in migration over the chase period (Fig. 7A) , which probably results from trimming of the N-linked, high-mannose glycans. It should be noted that the level of El increased slightly during ALENLVILNAASLAGTHGLVSFLVF E2/p7 7 p7/NS2 5 . Alignment of the HCV E2/p7 and p7/NS2 cleavage sites. The amino acid sequences around the E2/p7 and p7/NS2 cleavage sites are aligned for the following HCV isolates: HCV-H (14, 38), HCV-1 (11), HCV-J (39), HCV-JT (67), HCV-BK (66), HCV-T (9), HCV-J6 (55), and HCV-J8 (54). The single-letter code for amino acids is used. A hyphen indicates a residue identical to that of the HCV-H sequence.
the chase period (Fig. 7A) , in apparent conflict with the absence of any El-containing polyprotein precursors. This has been observed before and may be due to a delay in the formation of the epitope recognized by the anti-El MAb used for immunoprecipitation (15) .
Processing in the E2-NS2 region was more complex. After a 20-min pulse, three E2-specific proteins, including E2, E2-p7, and E2-NS2, were apparent after PNGaseF digestion (Fig. 7B) while the anti-NS2 antiserum recognized two products, E2-NS2 and NS2 (Fig. 7C) . These results indicate that cleavages at the El/E2 and 2/3 sites occur rapidly, perhaps cotranslationally, and are followed by delayed processing within the E2-NS2 region (see Discussion). As seen in Fig. 7B and C, the level of E2-NS2 decreased concomitantly with an increase in the levels of E2 and NS2 during the chase. This provides evidence that E2-NS2 is a discrete precursor of E2 and NS2 (27) , which has also been demonstrated recently for the HCV-BK strain (15) . The precursor-product relationship between E2-p7 and E2, if any, is less clear, and the results so far do not distinguish between a kinetic mechanism and an alternative pathway for the inefficient cleavage at the E2/p7 site. Cleavage at the p7/NS2 site relative to that at the E2/p7 site was efficient as evidenced by the disappearance of E2-NS2 and the low levels of p7-NS2 detected during the chase. This observation, to- gether with the decrease in the ratio of E2-p7 to E2 during the chase, suggests that E2-p7 may be cleaved slowly to produce E2. However, further experiments are needed to substantiate this conclusion, given the instability of these products during long chases in the presence of cycloheximide.
DISCUSSION
Earlier transient expression studies (25) (26) (27) and the work reported here have defined nine cleavage sites in the HCV-H polyprotein: C/El, E1/E2, E2/p7, p7/NS2, 2/3, 3/4A, 4A/4B, 4B/5A, and 5A/5B. These cleavages result in the production of at least 10 nonoverlapping polypeptides whose properties are summarized in Table 2 . Our studies and those utilizing the HCV-J strain (31) suggest that the primary processing events in the putative structural region and the NS2 region are likely to be catalyzed by host signal peptidase. Two HCV-encoded proteinases are required for processing the remainder of the polyprotein. The 2/3 cleavage appears to be mediated by a novel autoproteolytic activity, perhaps a Zn2'-dependent metalloproteinase, which encompasses the NS2 region and the NS3 serine proteinase domain (26, 32) . The remaining cleavages in the NS region are dependent on an active NS3 serine proteinase domain (2, 16, 25, 32, 47, 68) .
Although we believe it is likely that the E2/p7 and p7/NS2 cleavages are mediated by a host signal peptidase, the presence of a discrete E2-p7-NS2 precursor and a reasonably stable E2-p7 species (reference 15 and this report) suggests that these cleavages are not necessarily cotranslational (in contrast to the C/El and El/E2 cleavages). Delayed cleavage may reflect a requirement for additional posttranslational modifications or interactions with other host or viral components, or it may be due to the presence of a suboptimal signal peptidase cleavage site. Analysis of signal peptide sequences of several HCV strains showed that among all four putative signal peptidasemediated cleavage sites, the E2/p7 site has the lowest probability for signalase cleavage (21, 69) . This fits with the inefficient cleavage observed for the E2/p7 site compared with that for the p7/NS2 site in the pulse-chase analyses (Fig. 7) . The relatively low hydrophobicity in the core region of the putative signal peptide for p7 may be responsible for slow translocation or, more likely, for slow or inefficient processing by the signal peptidase (70) . On the other hand, it is possible that an a Based on the HCV-H strain (14) and the assumption that there is no trimming at the C termini of these proteins.
b For glycoproteins (El, E2, and E2-p7), the molecular weights of N-deglycosylated forms are given, with the molecular weights of glycosylated forms (gp) in brackets.
c Similarity is the arithmetic mean of comparison scores from several full-length HCV polypeptide sequences, calculated by using the modified Dayhoff table (28) 'ND, not determined.
alternative microsomal or viral proteinase is responsible for cleavage at this site. This processing scheme for the HCV structural-NS2 region has features similar to as well as distinct from those exhibited by flaviviruses and pestiviruses. For members of the flavivirus genus, the gene order is NH2-anchC-prM-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5-COOH and the mature virion proteins include C, M, and E (see reference 60 for a review). Cleavages generating the N termini of prM, E, and NS1, a nonstructural glycoprotein, are mediated by host signal peptidase. prM is later processed to pr (the N-terminal part of prM) and M (the C-terminal fragment), presumably by a Golgiassociated proteinase, shortly before virus release. Although earlier models proposed that cleavage at a C-terminal dibasic site of anchC (by the virus-encoded NS2B-3 serine proteinase) was responsible for production of mature virion C protein, this view has recently been challenged by evidence which indicates that cleavage at the dibasic site may be a prerequisite for signal peptidase cleavage (1, 45, 72) . For pestiviruses, the first protein of the open reading frame, p20, is an autoproteinase (71) responsible for p20/C cleavage to produce the N terminus of the nucleocapsid protein, C, which is followed by three virion envelope glycoproteins, EO, El, and E2 (61) . Cotranslational cleavage at the C/EO site and the C terminus of E2 generate an EO-E1-E2 precursor. Processing at the E1/E2 site, although slightly delayed, is also thought to be mediated by host signal peptidase. The EO/El cleavage site, similar to the NS1/2A site of flaviviruses (7), has a sequence that fulfills the (-1, -3) rule for signal peptidase cleavage sites, but it lacks an upstream hydrophobic region. Proteinases of novel specificity have been invoked for both cleavages (35, 60, 61) , although cleavage by signal peptidase has not been excluded. Thus, while signalasemediated cleavages appear to play an important role for processing in the structural region for all three genera in the flavivirus family, delayed cleavages catalyzed by proteinases other than host signal peptidase, such as the prM cleavage (flaviviruses) and perhaps the EO/E1 cleavage (pestiviruses), have not been identified for HCV.
Assuming that the C terminus of HCV E2 (polyprotein residue 746) does not undergo additional trimming, the Cterminal region of the E2 protein is characterized by stretches of hydrophobic amino acid residues punctuated by occasional charged residues which are highly conserved. Although short, the best candidates for potential membrane-spanning segments appear to be residues 699 to 714 and 731 to 744. A similar arrangement of sequences is found near the predicted C terminus of the El protein (residue 383), where uncharged residues 347 to 369 are followed by a conserved lysine residue and then a second hydrophobic region consisting of residues 371 to 381. These elements are reminiscent of those found near the C termini of flavivirus virion proteins M and E which appear to function as signal/anchor sequences and may also play a role in mediating specific interactions important for virion assembly. The 63-residue p7 protein is composed mainly of uncharged polar or hydrophobic residues punctuated by a few conserved charged residues (Fig. 5) . One model for the topology of p7, constrained by lumenal signal peptidase cleavages at the N and C termini, predicts that residues 764 to 778 and 782 to 803 constitute transmembrane segments which are separated by a few charged residues localized on the cytoplasmic side of the membrane. Whether p7 corresponds to a structural or NS protein remains to be determined.
At least for our clone of HCV-H, inefficient processing at the E2/p7 site leads to the production of two polypeptides containing E2 sequences, E2 and E2-p7. Although it is generally believed that the E2 glycoprotein is a structural protein, the existence of E2-p7 raises the possibility that this protein could also be a virion component or possibly a distinct cell-associated form of the E2 protein. However, although E2-p7 was found to be relatively stable in our experiments (reference 15 and this report), preliminary studies using constructs derived from a distinct HCV subtype, HCV-BK (66) , suggest that processing at the E2/p7 site can be more efficient (data not shown). Further studies, with additional independent cDNA constructs, are required to determine if strain-specific differences in processing at this site exist. In any case, roles for VOL. 68, 1994 these proteins in HCV virion assembly or RNA replication will remain speculative until it becomes possible to examine virusencoded proteins in authentic HCV-infected cells and virions and to assess their importance in the life cycle via genetic and biochemical studies.
